切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2020, Vol. 10 ›› Issue (03) : 131 -137. doi: 10.3877/cma.j.issn.2095-1221.2020.03.001

所属专题: 文献

论著

miR-363-3p靶向TWIST1调控上皮间质转化抑制非小细胞肺癌A549细胞迁移和侵袭
李月华1, 曹爽1,()   
  1. 1. 442000 十堰,湖北省十堰市人民医院(湖北医药学院附属人民医院)肿瘤科
  • 收稿日期:2019-05-27 出版日期:2020-06-01
  • 通信作者: 曹爽

Effects of MiR-363-3p targeting TWIST1 on the migration and invasion of A549 cells by regulating epithelial-mesenchymal transition

Yuehua Li1, Shuang Cao1,()   

  1. 1. Department of Oncology, People's Hosptial of Shiyan City, Hubei Medical College Affiliated People's Hospital, Shiyan 442000, China
  • Received:2019-05-27 Published:2020-06-01
  • Corresponding author: Shuang Cao
引用本文:

李月华, 曹爽. miR-363-3p靶向TWIST1调控上皮间质转化抑制非小细胞肺癌A549细胞迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(03): 131-137.

Yuehua Li, Shuang Cao. Effects of MiR-363-3p targeting TWIST1 on the migration and invasion of A549 cells by regulating epithelial-mesenchymal transition[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2020, 10(03): 131-137.

目的

探讨miR-363-3p靶向TWIST1调控非小细胞肺癌A549细胞迁移和侵袭的分子机制。

方法

将体外培养的A549细胞分为空白对照组(细胞未做任何处理);模拟物对照组(转染miR-363-3p模拟物阴性对照);模拟物组(转染miR-363-3p模拟物);后期实验另设:模拟物+ pcDNA组(转染miR-363-3p模拟物和pcDNA3.1空载体质粒);模拟物+ TWIST1组(转染miR-363-3p模拟物和pcDNA3.1-TWIST1过表达质粒)。采用RT-PCR检测细胞中miR-363-3p的表达,Western blot检测细胞中TWIST1蛋白和上皮间质转化(EMT)相关蛋白Vimentin、E-cadherin的表达,Transwell小室实验检测细胞的迁移和侵袭。双荧光素酶报告基因实验检测miR-363-3p和TWIST1的靶向关系。两组间比较采用独立样本t检验,多组间比较采用单因素方差分析,组间两两比较采用LSD-t检验。

结果

与空白对照组和模拟物对照组比较,模拟物组A549细胞中miR-363-3p表达水平(1.00±0.08、0.97±0.05比3.82±0.45)升高,TWIST1 mRNA (1.00±0.06、0.98±0.06比0.39±0.02)和蛋白的表达水平(0.81±0.05、0.78±0.06比0.42±0.02)降低,差异具有统计学意义(P均< 0.05)。与空白对照组和模拟物对照组比较,模拟物组A549细胞Vimentin蛋白表达水平(0.58±0.04、0.55±0.05比0.36±0.03)降低,E-cadherin蛋白的表达水平(0.22±0.02、0.25±0.03比0.47±0.03)增高,迁移细胞数(85.75±5.45、83.52±6.85比53.05±4.50)和侵袭细胞数(128.26±6.15、125.95±8.05比71.64±5.75)降低,差异有统计学意义(P均< 0.05)。与模拟物对照组比较,模拟物组细胞中Vimentin蛋白的表达水平(0.55±0.05比0.36±0.03)降低,而E-cadherin蛋白表达水平(0.25±0.03比0.47±0.03)升高,迁移细胞数(83.52±6.85比53.05±4.50)和侵袭细胞数(125.95±8.05比71.64±5.75)均减少(P均< 0.05)。TWIST1是miR-363-3p潜在的靶基因。与模拟物+ pcDNA3.1组比较,模拟物+ TWIST1组A549细胞中Vimentin蛋白的表达水平(0.32±0.02比0.42±0.03)升高,而E-cadherin蛋白表达水平(0.56±0.04比0.38±0.03)降低,A549细胞的迁移数(49.45±4.22比67.52±5.05)和侵袭数(72.45±5.73比108.35±6.56)增加(P均< 0.05)。

结论

miR-363-3p可通过靶向TWIST1调控EMT抑制A549细胞迁移和侵袭。

Objective

To explore the molecular mechanism of miR-363-3p targeting TWIST1 regulates migration and invasion of non-small cell lung cancer A549 cells.

Methods

A549 cells cultured in vitro were divided into the blank control group (without any treatment) , mimic control group (transfected with miR-363-3p mimic negative control) , mimic group (transfected with miR-363-3p mimic) . Different groups were set up in the later experiment, including mimic+pcDNA group (transfected with miR-363-3p mimic and pcDNA3.1 empty vector plasmid) , mimic+TWIST1 group (transfected with miR-363-3p mimic and pcDNA3.1 TWIST1 overexpression plasmid) .The expression of miR-363-3p was detected by RT-PCR. The expression of TWIST1 protein and epithelial-mesenchymal transition (EMT) -related proteins Vimentin and E-cadherin were detected by Western blot, and the migration and invasion of cells were detected by Transwell chamber. The targeting relationship between miR-363-3p and TWIST1 was examed by dual luciferase reporter gene assay. Independent sample t-test was used for comparison between the two groups, single factor analysis of variance was used for comparison between multiple groups, and LSD-t test was used for comparison between the two groups.

Results

Compared with the blank control group and mimic control group, the expression of miR-363-3p (1.00±0.08, 0.97±0.05 vs 3.82±0.45) in A549 cells of mimic group were increased, and the TWIST1 mRNA and protein expression levels were decreased (1.00 ±0.06, 0.98±0.06 vs 0.39±0.02) , (0.81±0.05, 0.78±0.06 vs 0.42±0.02) , the difference was statistically significant (P < 0.05) . Compared with the blank control group and the mimic control group, the expression level of Vimentin protein in the mimic group A549 cells as well as the number of migration cells (85.75±5.45, 83.52±6.85 vs 53.05±4.50) and invasive cells (128.26±6.15, 125.95±8.05 vs 71.64±5.75) were decreased (0.58±0.04, 0.55±0.05 vs 0.36±0.03) , while the expression level of E-cadherin protein was increased (0.22±0.02, 0.25±0.03 vs 0.47±0.03) , the difference was statistically significant (all P < 0.05) . Compared with the mimic control group, the expression level of Vimentin protein in the simulant group cells (0.55±0.05 vs 0.36±0.03) and the number of migrating cells (83.52±6.85 vs 53.05±4.50) as well as invasive cells (125.95±8.05 vs 71.64±5.75) were decreased, while the expression level of E-cadherin protein (0.25±0.03 vs 0.47±0.03) was increased (all P < 0.05) . TWIST1 is a potential target gene of miR-363-3p. Compared with the mimic+pcDNA3.1 group, the expression level of Vimentin protein in A549 cells in the mimic+TWIST1 group was increased (0.32±0.02 vs 0.42±0.03) , while the expression level of E-cadherin protein (0.56±0.04 vs 0.38±0.03) was decreased. The migration number (49.45±4.22 vs 67.52±5.05) and invasion number (72.45±5.73 vs 108.35±6.56) of A549 cells were increased (all P < 0.05) .

Conclusion

MiR-363-3p could inhibit migration and invasion of A549 cells by regulating EMT through targeting TWIST1.

表1 引物序列信息
图1 Western blot检测TWIST1蛋白的表达
表2 模拟物干预后A549细胞中miR-363-3p及TWIST1 mRNA和蛋白表达水平(±sn = 3)
图2 TWIST1 3' UTR与miR-363-3p的结合位点
图3 模拟物及抑制剂干预细胞后双荧光素酶相对活性
图4 Western blot检测Vimentin和E-cadherin蛋白的表达
表3 miR-363-3p过表达对A549细胞中Vimentin和E-cadherin蛋白的相对表达水平(±sn = 3)
图5 倒置显微镜下观察miR-363-3p过表达对A549细胞迁移和侵袭的影响(结晶紫染色,×200)
表4 miR-363-3p过表达对A549细胞侵袭和迁移的影响(±sn = 3)
图6 倒置显微镜下观察TWIST1对miR-363-3p过表达的A549细胞EMT、迁移和侵袭的影响(结晶紫染色,×200)
图7 Western blot检测Vimentin和E-cadherin蛋白表达
表5 TWIST1对miR-363-3p过表达的A549细胞EMT、迁移和侵袭的影响(±sn = 3)
1
Liu Z, Liang X, Li X, et al. MiRNA-21 functions in ionizing radiation-induced epithelium-to-mesenchymal transition (EMT) by downregulating PTEN[J]. Toxicol Res (Camb), 2019, 8(3):328-340.
2
Li Y, Luo JT, Liu YM, et al. miRNA-145/miRNA-205 inhibits proliferation and invasion of uveal melanoma cells by targeting NPR1/CDC42[J]. Int J Ophthalmol, 2020, 13(5):718-724.
3
Su WZ, Ren LF. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17[J]. Eur Rev Med Pharmacol Sci, 2019, 23(8):3390-3400.
4
Hu F, Min J, Cao X, et al. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4[J]. Biochem Biophys Res Commun, 2016, 474(1):35-42.
5
翟頔, 温馨, 皮静楠, 等. miR-363-3p在胃癌组织中的表达及其对细胞系HGC-27增殖、迁移与侵袭功能的影响[J]. 基础医学与临床, 2016, 36(5):638-643.
6
Liu J, Li Q, Li R, et al. MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA[J]. Am J Cancer Res, 2017, 7(1):148-158.
7
胡情保, 王亚红, 陈婷, 等. miR-363-3p和miR-5100在非小细胞肺癌中的表达及其临床意义[J]. 现代肿瘤医学, 2017, 25(10):1560-1563.
8
Mansoori B, Mohammadi A, Naghizadeh S, et al. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer[J]. J Cell Physiol, 2020, 235(2): 920-931.
9
Li Y, Wang YW, Chen X, et al. MicroRNA-4472 promotes tumor proliferation and aggressiveness in breast cancer by targeting RGMA and inducing EMT[J]. Clin Breast Cancer, 2020, 20(2):e113-e126.
10
Liu H, Ren SY, Qu Y, et al. MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk[J]. Kaohsiung J Med Sci, 2020, 36(4):265-273.
11
Park H, Lee M, Jeong J, et al. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p[J]. Gynecol Oncol, 2014, 135(3):565-572.
12
Li Y, Chen D, Li Y, et al. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer[J]. Oncol Rep, 2016, 35(4):1967-1978.
13
Chao CC, Chen PC, Chiou PC, et al. Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to twist[J]. Clin Sci (Lond), 2019, 133(5):709-722.
14
崔凯, 王武平, 孙盈, 等. 非小细胞肺癌中Twist通过TGF-β/Smad3信号通路促进EMT的发生[J]. 陕西医学杂志, 2016, 45(11):1462-1465.
15
Hui L, Zhang S, Dong X, et al. Prognostic significance of twist and N-cadherin expression in NSCLC[J]. PLos One, 2013, 8(4):e62171.
16
Han Z, Liu L, Liu Y, et al. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2014, 7(8):4774-4781.
17
Wang Y, Chen T, Huang H, et al. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma[J]. Oncotarget, 2017, 8(12):20133-20144.
18
Xu S, Zhang ZH, Fu L, et al. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3-and β-catenin-mediated epithelial-mesenchymal transition[J]. Cancer Sci, 2020, 111(1):59-71.
19
Morais EF, Pinheiro JC, Lira JA, et al. Prognostic value of the immunohistochemical detection of epithelial-mesenchymal transition biomarkers in oral epithelial dysplasia: a systematic review[J]. Med Oral Patol Oral Cir Bucal, 2020, 25(2):e205-e216.
20
Brabletz T, Kalluri R, Nieto MA, et al. EMT in cancer[J]. Nat Rev Cancer, 2018, 18(2):128-134.
21
商旭芳, 董丽. 非小细胞肺癌组织中E-cadherin及Vimentin的表达与肺门、纵隔淋巴结转移的关系[J]. 四川医学, 2016, 37(3):292-295.
22
Goit M. Twist基因对结肠癌细胞系侵袭转移影响的体外实验[D]. 天津:天津医科大学, 2013.
23
张丽永. Twist基因质粒构建及其与结肠癌细胞EMT的相关性研究[D]. 天津:天津医科大学, 2010.
[1] 黄瑞娟, 德奇, 巴特, 周彪. 对人脐带间充质干细胞外泌体影响热损伤人皮肤成纤维细胞迁移的分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 229-234.
[2] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[3] 刘雪峰, 韩海峰, 杨硕, 逯景辉. 腹腔镜腹壁侵袭性纤维瘤病切除联合腹壁重建:单中心经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 374-379.
[4] 徐天亮, 程干思, 吴亚平, 龚荣, 胡洁, 段群娣, 李承慧. 奥希替尼联合安罗替尼二线治疗转移性NSCLC的疗效分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 520-522.
[5] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[6] 孟原竹, 蒋国路, 陈小兵, 蒋莉. 肺结核合并侵袭性肺曲霉感染临床特征及危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 541-543.
[7] 魏婷婷, 胡小红, 龚自强, 熊鹿. 老年非小细胞肺癌组织ARPC2表达及与预后关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 584-586.
[8] 杜静怡, 徐兴祥. 循环肿瘤细胞在非小细胞肺癌中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 596-600.
[9] 黄承路, 廖飞, 刘显平, 王志强. 血清外泌体Has_circ_0060937过度表达与NSCLC转移和不良预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 490-494.
[10] 陈坤, 何傅梅, 方婷, 陈文瑞. 血清sCD73与EGFR/ALK野生型非小细胞肺癌免疫治疗效果的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 504-507.
[11] 朱超男, 王帅, 王文博, 郑贸根, 程远, 陈志全. 非小细胞肺癌患者组织miR-31-5p表达与临床病理特征及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 508-510.
[12] 卞天丹, 宋爽, 陶臻. 高毒力肺炎克雷伯菌分子学机制研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 438-441.
[13] 莫钊鸿, 翟航, 苏日顺, 孟泓宇, 罗豪, 陈文豪, 许瑞云. U2AF2表达对肝细胞癌增殖和迁移的影响及其与预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 336-341.
[14] 李世明, 黄蔚, 刘玲. HMGB1介导脓毒症相关凝血功能障碍的作用机制及其治疗进展[J]. 中华重症医学电子杂志, 2023, 09(03): 269-273.
[15] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
阅读次数
全文


摘要